Estrogen receptor signaling as a target for novel breast cancer therapeutics - ScienceDirect
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
Identification of pathway-selective estrogen receptor ligands that inhibit NF-κB transcriptional activity | PNAS
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
Major estrogen receptor (ER)-mediated signaling pathways engaged by... | Download Scientific Diagram
Four major mechanisms of estrogen and estrogen receptors (ER). (I)... | Download Scientific Diagram
Fulvestrant | Aromatase inhibitor | Buy Faslodex from Supplier AdooQ®
Potentiation of ICI182,780 (Fulvestrant)-induced Estrogen Receptor-α Degradation by the Estrogen Receptor-related Receptor-α Inverse Agonist XCT790* - Journal of Biological Chemistry
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment - Abstract - Europe PMC
Estradiol Suppresses NF-κB Activation through Coordinated Regulation of let-7a and miR-125b in Primary Human Macrophages | The Journal of Immunology
Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram
Cancers | Free Full-Text | Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer | HTML
Activation of Transcription by Estrogen Receptor α and β Is Cell Type- and Promoter-dependent* - Journal of Biological Chemistry
Estrogen signaling: An emanating therapeutic target for breast cancer treatment - ScienceDirect
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance | Oncology
Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram
Full antagonism of the estrogen receptor without a prototypical ligand side chain | Nature Chemical Biology
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
Cancers | Free Full-Text | Classical and Non-Classical Progesterone Signaling in Breast Cancers | HTML
Targeting Androgen/Estrogen Receptors Crosstalk in Cancer: Trends in Cancer
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER | Endocrinology
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer | Nature Communications
